Search for instruments
Transgene SA
Transgene SA is a biotech firm that specializes in developing innovative immunotherapies for cancer and infectious diseases. Their proprietary technology platform creates genetically modified viruses that selectively target and destroy cancer cells while leaving healthy cells unharmed. Their lead product candidate, TG4010, is a therapeutic vaccine for non-small cell lung cancer that has shown promising results in clinical trials. Transgene has a pipeline of other immunotherapies in development, including treatments for hepatitis B and solid tumors. With a team of experienced scientists and a commitment to advancing immunotherapy, Transgene is dedicated to improving the lives of patients with serious diseases.Instrument specification for Transgene SA
Start trading now with fast account opening.
Sign-up now to trade the most active markets
Open account
Boasting over 20 years in the markets, leading analysis tools and thousands of satisfied clients, OANDA is proud to be an award-winning broker.
Get access to the most active of global markets with thousands of trading instruments at your fingertips, as well leading technical tools to assist in your analysis.
Trade without unnecessary costs and total pricing transparency - OANDA offers zero-commission on major instruments, transparent pricing.
